1 Systemic Infection Therapy Market Overview 1.1 Product Overview and Scope of Systemic Infection Therapy 1.2 Systemic Infection Therapy Segment by Type 1.2.1 Global Systemic Infection Therapy Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Antibacterial Drugs 1.2.3 Anti-viral Drugs 1.2.4 Antifungal Drugs 1.3 Systemic Infection Therapy Segment by Application 1.3.1 Global Systemic Infection Therapy Sales Comparison by Application: (2021-2027) 1.3.2 Oral 1.3.3 Intravenous 1.3.4 Topical 1.4 Global Systemic Infection Therapy Market Size Estimates and Forecasts 1.4.1 Global Systemic Infection Therapy Revenue 2016-2027 1.4.2 Global Systemic Infection Therapy Sales 2016-2027 1.4.3 Systemic Infection Therapy Market Size by Region: 2016 Versus 2021 Versus 2027 2 Systemic Infection Therapy Market Competition by Manufacturers 2.1 Global Systemic Infection Therapy Sales Market Share by Manufacturers (2016-2021) 2.2 Global Systemic Infection Therapy Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Systemic Infection Therapy Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Systemic Infection Therapy Manufacturing Sites, Area Served, Product Type 2.5 Systemic Infection Therapy Market Competitive Situation and Trends 2.5.1 Systemic Infection Therapy Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Systemic Infection Therapy Players Market Share by Revenue 2.5.3 Global Systemic Infection Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Systemic Infection Therapy Retrospective Market Scenario by Region 3.1 Global Systemic Infection Therapy Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Systemic Infection Therapy Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Systemic Infection Therapy Market Facts & Figures by Country 3.3.1 North America Systemic Infection Therapy Sales by Country 3.3.2 North America Systemic Infection Therapy Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Systemic Infection Therapy Market Facts & Figures by Country 3.4.1 Europe Systemic Infection Therapy Sales by Country 3.4.2 Europe Systemic Infection Therapy Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Systemic Infection Therapy Market Facts & Figures by Region 3.5.1 Asia Pacific Systemic Infection Therapy Sales by Region 3.5.2 Asia Pacific Systemic Infection Therapy Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Systemic Infection Therapy Market Facts & Figures by Country 3.6.1 Latin America Systemic Infection Therapy Sales by Country 3.6.2 Latin America Systemic Infection Therapy Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Systemic Infection Therapy Market Facts & Figures by Country 3.7.1 Middle East and Africa Systemic Infection Therapy Sales by Country 3.7.2 Middle East and Africa Systemic Infection Therapy Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Systemic Infection Therapy Historic Market Analysis by Type 4.1 Global Systemic Infection Therapy Sales Market Share by Type (2016-2021) 4.2 Global Systemic Infection Therapy Revenue Market Share by Type (2016-2021) 4.3 Global Systemic Infection Therapy Price by Type (2016-2021) 5 Global Systemic Infection Therapy Historic Market Analysis by Application 5.1 Global Systemic Infection Therapy Sales Market Share by Application (2016-2021) 5.2 Global Systemic Infection Therapy Revenue Market Share by Application (2016-2021) 5.3 Global Systemic Infection Therapy Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Abbott Laboratories 6.1.1 Abbott Laboratories Corporation Information 6.1.2 Abbott Laboratories Description and Business Overview 6.1.3 Abbott Laboratories Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Abbott Laboratories Systemic Infection Therapy Product Portfolio 6.1.5 Abbott Laboratories Recent Developments/Updates 6.2 Merck & Co. 6.2.1 Merck & Co. Corporation Information 6.2.2 Merck & Co. Description and Business Overview 6.2.3 Merck & Co. Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Merck & Co. Systemic Infection Therapy Product Portfolio 6.2.5 Merck & Co. Recent Developments/Updates 6.3 Pfizer 6.3.1 Pfizer Corporation Information 6.3.2 Pfizer Description and Business Overview 6.3.3 Pfizer Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Pfizer Systemic Infection Therapy Product Portfolio 6.3.5 Pfizer Recent Developments/Updates 6.4 GlaxoSmithKline 6.4.1 GlaxoSmithKline Corporation Information 6.4.2 GlaxoSmithKline Description and Business Overview 6.4.3 GlaxoSmithKline Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.4.4 GlaxoSmithKline Systemic Infection Therapy Product Portfolio 6.4.5 GlaxoSmithKline Recent Developments/Updates 6.5 Novartis 6.5.1 Novartis Corporation Information 6.5.2 Novartis Description and Business Overview 6.5.3 Novartis Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Novartis Systemic Infection Therapy Product Portfolio 6.5.5 Novartis Recent Developments/Updates 6.6 Johnson & Johnson 6.6.1 Johnson & Johnson Corporation Information 6.6.2 Johnson & Johnson Description and Business Overview 6.6.3 Johnson & Johnson Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Johnson & Johnson Systemic Infection Therapy Product Portfolio 6.6.5 Johnson & Johnson Recent Developments/Updates 6.7 Sun Pharmaceuticals 6.6.1 Sun Pharmaceuticals Corporation Information 6.6.2 Sun Pharmaceuticals Description and Business Overview 6.6.3 Sun Pharmaceuticals Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sun Pharmaceuticals Systemic Infection Therapy Product Portfolio 6.7.5 Sun Pharmaceuticals Recent Developments/Updates 6.8 Roche 6.8.1 Roche Corporation Information 6.8.2 Roche Description and Business Overview 6.8.3 Roche Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Roche Systemic Infection Therapy Product Portfolio 6.8.5 Roche Recent Developments/Updates 6.9 Astra Zeneca 6.9.1 Astra Zeneca Corporation Information 6.9.2 Astra Zeneca Description and Business Overview 6.9.3 Astra Zeneca Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Astra Zeneca Systemic Infection Therapy Product Portfolio 6.9.5 Astra Zeneca Recent Developments/Updates 6.10 Wockhardt 6.10.1 Wockhardt Corporation Information 6.10.2 Wockhardt Description and Business Overview 6.10.3 Wockhardt Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Wockhardt Systemic Infection Therapy Product Portfolio 6.10.5 Wockhardt Recent Developments/Updates 6.11 Mylan Pharma 6.11.1 Mylan Pharma Corporation Information 6.11.2 Mylan Pharma Systemic Infection Therapy Description and Business Overview 6.11.3 Mylan Pharma Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Mylan Pharma Systemic Infection Therapy Product Portfolio 6.11.5 Mylan Pharma Recent Developments/Updates 6.12 MicuRx Pharmaceuticals 6.12.1 MicuRx Pharmaceuticals Corporation Information 6.12.2 MicuRx Pharmaceuticals Systemic Infection Therapy Description and Business Overview 6.12.3 MicuRx Pharmaceuticals Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.12.4 MicuRx Pharmaceuticals Systemic Infection Therapy Product Portfolio 6.12.5 MicuRx Pharmaceuticals Recent Developments/Updates 6.13 Jincheng Pharmaceutical 6.13.1 Jincheng Pharmaceutical Corporation Information 6.13.2 Jincheng Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.13.3 Jincheng Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Jincheng Pharmaceutical Systemic Infection Therapy Product Portfolio 6.13.5 Jincheng Pharmaceutical Recent Developments/Updates 6.14 Renhe Pharmacy 6.14.1 Renhe Pharmacy Corporation Information 6.14.2 Renhe Pharmacy Systemic Infection Therapy Description and Business Overview 6.14.3 Renhe Pharmacy Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Renhe Pharmacy Systemic Infection Therapy Product Portfolio 6.14.5 Renhe Pharmacy Recent Developments/Updates 6.15 Hengrui Medicine 6.15.1 Hengrui Medicine Corporation Information 6.15.2 Hengrui Medicine Systemic Infection Therapy Description and Business Overview 6.15.3 Hengrui Medicine Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Hengrui Medicine Systemic Infection Therapy Product Portfolio 6.15.5 Hengrui Medicine Recent Developments/Updates 6.16 Huluwa Pharmaceutical 6.16.1 Huluwa Pharmaceutical Corporation Information 6.16.2 Huluwa Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.16.3 Huluwa Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Huluwa Pharmaceutical Systemic Infection Therapy Product Portfolio 6.16.5 Huluwa Pharmaceutical Recent Developments/Updates 6.17 Fushine Pharmaceutical 6.17.1 Fushine Pharmaceutical Corporation Information 6.17.2 Fushine Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.17.3 Fushine Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Fushine Pharmaceutical Systemic Infection Therapy Product Portfolio 6.17.5 Fushine Pharmaceutical Recent Developments/Updates 6.18 Baiyunshan Pharmaceutical 6.18.1 Baiyunshan Pharmaceutical Corporation Information 6.18.2 Baiyunshan Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.18.3 Baiyunshan Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Baiyunshan Pharmaceutical Systemic Infection Therapy Product Portfolio 6.18.5 Baiyunshan Pharmaceutical Recent Developments/Updates 6.19 Harbin Pharmaceutical 6.19.1 Harbin Pharmaceutical Corporation Information 6.19.2 Harbin Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.19.3 Harbin Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.19.4 Harbin Pharmaceutical Systemic Infection Therapy Product Portfolio 6.19.5 Harbin Pharmaceutical Recent Developments/Updates 6.20 China National Pharmaceutical 6.20.1 China National Pharmaceutical Corporation Information 6.20.2 China National Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.20.3 China National Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.20.4 China National Pharmaceutical Systemic Infection Therapy Product Portfolio 6.20.5 China National Pharmaceutical Recent Developments/Updates 6.21 Luoxin Pharmaceuticals 6.21.1 Luoxin Pharmaceuticals Corporation Information 6.21.2 Luoxin Pharmaceuticals Systemic Infection Therapy Description and Business Overview 6.21.3 Luoxin Pharmaceuticals Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.21.4 Luoxin Pharmaceuticals Systemic Infection Therapy Product Portfolio 6.21.5 Luoxin Pharmaceuticals Recent Developments/Updates 6.22 Yangtze River Pharmaceutical 6.22.1 Yangtze River Pharmaceutical Corporation Information 6.22.2 Yangtze River Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.22.3 Yangtze River Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.22.4 Yangtze River Pharmaceutical Systemic Infection Therapy Product Portfolio 6.22.5 Yangtze River Pharmaceutical Recent Developments/Updates 6.23 China Resources Pharmaceutical 6.23.1 China Resources Pharmaceutical Corporation Information 6.23.2 China Resources Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.23.3 China Resources Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.23.4 China Resources Pharmaceutical Systemic Infection Therapy Product Portfolio 6.23.5 China Resources Pharmaceutical Recent Developments/Updates 6.24 North China Pharmaceutical 6.24.1 North China Pharmaceutical Corporation Information 6.24.2 North China Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.24.3 North China Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.24.4 North China Pharmaceutical Systemic Infection Therapy Product Portfolio 6.24.5 North China Pharmaceutical Recent Developments/Updates 6.25 ReYoung Pharmaceutical 6.25.1 ReYoung Pharmaceutical Corporation Information 6.25.2 ReYoung Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.25.3 ReYoung Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.25.4 ReYoung Pharmaceutical Systemic Infection Therapy Product Portfolio 6.25.5 ReYoung Pharmaceutical Recent Developments/Updates 6.26 Chia Tai-Tianqing Pharmaceutical 6.26.1 Chia Tai-Tianqing Pharmaceutical Corporation Information 6.26.2 Chia Tai-Tianqing Pharmaceutical Systemic Infection Therapy Description and Business Overview 6.26.3 Chia Tai-Tianqing Pharmaceutical Systemic Infection Therapy Sales, Revenue and Gross Margin (2016-2021) 6.26.4 Chia Tai-Tianqing Pharmaceutical Systemic Infection Therapy Product Portfolio 6.26.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates 7 Systemic Infection Therapy Manufacturing Cost Analysis 7.1 Systemic Infection Therapy Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Systemic Infection Therapy 7.4 Systemic Infection Therapy Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Systemic Infection Therapy Distributors List 8.3 Systemic Infection Therapy Customers 9 Systemic Infection Therapy Market Dynamics 9.1 Systemic Infection Therapy Industry Trends 9.2 Systemic Infection Therapy Growth Drivers 9.3 Systemic Infection Therapy Market Challenges 9.4 Systemic Infection Therapy Market Restraints 10 Global Market Forecast 10.1 Systemic Infection Therapy Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Systemic Infection Therapy by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Systemic Infection Therapy by Type (2022-2027) 10.2 Systemic Infection Therapy Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Systemic Infection Therapy by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Systemic Infection Therapy by Application (2022-2027) 10.3 Systemic Infection Therapy Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Systemic Infection Therapy by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Systemic Infection Therapy by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Systemic Infection Therapy Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Systemic Infection Therapy Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Systemic Infection Therapy Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Systemic Infection Therapy Covered in This Study Table 5. Global Systemic Infection Therapy Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Systemic Infection Therapy Sales Market Share by Manufacturers (2016-2021) Table 7. Global Systemic Infection Therapy Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Systemic Infection Therapy Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Systemic Infection Therapy Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Systemic Infection Therapy Manufacturing Sites and Area Served Table 11. Manufacturers Systemic Infection Therapy Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Systemic Infection Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Infection Therapy as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Systemic Infection Therapy Sales by Region (2016-2021) & (K Units) Table 16. Global Systemic Infection Therapy Sales Market Share by Region (2016-2021) Table 17. Global Systemic Infection Therapy Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Systemic Infection Therapy Sales by Country (2016-2021) & (K Units) Table 19. North America Systemic Infection Therapy Sales Market Share by Country (2016-2021) Table 20. North America Systemic Infection Therapy Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Systemic Infection Therapy Revenue Market Share by Country (2016-2021) Table 22. Europe Systemic Infection Therapy Sales by Country (2016-2021) & (K Units) Table 23. Europe Systemic Infection Therapy Sales Market Share by Country (2016-2021) Table 24. Europe Systemic Infection Therapy Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Systemic Infection Therapy Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Systemic Infection Therapy Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Systemic Infection Therapy Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Systemic Infection Therapy Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Systemic Infection Therapy Revenue Market Share by Region (2016-2021) Table 30. Latin America Systemic Infection Therapy Sales by Country (2016-2021) & (K Units) Table 31. Latin America Systemic Infection Therapy Sales Market Share by Country (2016-2021) Table 32. Latin America Systemic Infection Therapy Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Systemic Infection Therapy Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Systemic Infection Therapy Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Systemic Infection Therapy Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Systemic Infection Therapy Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Systemic Infection Therapy Revenue Market Share by Country (2016-2021) Table 38. Global Systemic Infection Therapy Sales (K Units) by Type (2016-2021) Table 39. Global Systemic Infection Therapy Sales Market Share by Type (2016-2021) Table 40. Global Systemic Infection Therapy Revenue (Million US$) by Type (2016-2021) Table 41. Global Systemic Infection Therapy Revenue Share by Type (2016-2021) Table 42. Global Systemic Infection Therapy Price (US$/Unit) by Type (2016-2021) Table 43. Global Systemic Infection Therapy Sales (K Units) by Application (2016-2021) Table 44. Global Systemic Infection Therapy Sales Market Share by Application (2016-2021) Table 45. Global Systemic Infection Therapy Revenue (Million US$) by Application (2016-2021) Table 46. Global Systemic Infection Therapy Revenue Share by Application (2016-2021) Table 47. Global Systemic Infection Therapy Price (US$/Unit) by Application (2016-2021) Table 48. Abbott Laboratories Corporation Information Table 49. Abbott Laboratories Description and Business Overview Table 50. Abbott Laboratories Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Abbott Laboratories Systemic Infection Therapy Product Table 52. Abbott Laboratories Recent Developments/Updates Table 53. Merck & Co. Corporation Information Table 54. Merck & Co. Description and Business Overview Table 55. Merck & Co. Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Merck & Co. Systemic Infection Therapy Product Table 57. Merck & Co. Recent Developments/Updates Table 58. Pfizer Corporation Information Table 59. Pfizer Description and Business Overview Table 60. Pfizer Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Pfizer Systemic Infection Therapy Product Table 62. Pfizer Recent Developments/Updates Table 63. GlaxoSmithKline Corporation Information Table 64. GlaxoSmithKline Description and Business Overview Table 65. GlaxoSmithKline Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. GlaxoSmithKline Systemic Infection Therapy Product Table 67. GlaxoSmithKline Recent Developments/Updates Table 68. Novartis Corporation Information Table 69. Novartis Description and Business Overview Table 70. Novartis Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Novartis Systemic Infection Therapy Product Table 72. Novartis Recent Developments/Updates Table 73. Johnson & Johnson Corporation Information Table 74. Johnson & Johnson Description and Business Overview Table 75. Johnson & Johnson Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Johnson & Johnson Systemic Infection Therapy Product Table 77. Johnson & Johnson Recent Developments/Updates Table 78. Sun Pharmaceuticals Corporation Information Table 79. Sun Pharmaceuticals Description and Business Overview Table 80. Sun Pharmaceuticals Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Sun Pharmaceuticals Systemic Infection Therapy Product Table 82. Sun Pharmaceuticals Recent Developments/Updates Table 83. Roche Corporation Information Table 84. Roche Description and Business Overview Table 85. Roche Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. Roche Systemic Infection Therapy Product Table 87. Roche Recent Developments/Updates Table 88. Astra Zeneca Corporation Information Table 89. Astra Zeneca Description and Business Overview Table 90. Astra Zeneca Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Astra Zeneca Systemic Infection Therapy Product Table 92. Astra Zeneca Recent Developments/Updates Table 93. Wockhardt Corporation Information Table 94. Wockhardt Description and Business Overview Table 95. Wockhardt Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Wockhardt Systemic Infection Therapy Product Table 97. Wockhardt Recent Developments/Updates Table 98. Mylan Pharma Corporation Information Table 99. Mylan Pharma Description and Business Overview Table 100. Mylan Pharma Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Mylan Pharma Systemic Infection Therapy Product Table 102. Mylan Pharma Recent Developments/Updates Table 103. MicuRx Pharmaceuticals Corporation Information Table 104. MicuRx Pharmaceuticals Description and Business Overview Table 105. MicuRx Pharmaceuticals Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. MicuRx Pharmaceuticals Systemic Infection Therapy Product Table 107. MicuRx Pharmaceuticals Recent Developments/Updates Table 108. Jincheng Pharmaceutical Corporation Information Table 109. Jincheng Pharmaceutical Description and Business Overview Table 110. Jincheng Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Jincheng Pharmaceutical Systemic Infection Therapy Product Table 112. Jincheng Pharmaceutical Recent Developments/Updates Table 113. Renhe Pharmacy Corporation Information Table 114. Renhe Pharmacy Description and Business Overview Table 115. Renhe Pharmacy Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Renhe Pharmacy Systemic Infection Therapy Product Table 117. Renhe Pharmacy Recent Developments/Updates Table 118. Hengrui Medicine Corporation Information Table 119. Hengrui Medicine Description and Business Overview Table 120. Hengrui Medicine Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Hengrui Medicine Systemic Infection Therapy Product Table 122. Hengrui Medicine Recent Developments/Updates Table 123. Huluwa Pharmaceutical Corporation Information Table 124. Huluwa Pharmaceutical Description and Business Overview Table 125. Huluwa Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Huluwa Pharmaceutical Systemic Infection Therapy Product Table 127. Huluwa Pharmaceutical Recent Developments/Updates Table 128. Fushine Pharmaceutical Corporation Information Table 129. Fushine Pharmaceutical Description and Business Overview Table 130. Fushine Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Fushine Pharmaceutical Systemic Infection Therapy Product Table 132. Fushine Pharmaceutical Recent Developments/Updates Table 133. Baiyunshan Pharmaceutical Corporation Information Table 134. Baiyunshan Pharmaceutical Description and Business Overview Table 135. Baiyunshan Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Baiyunshan Pharmaceutical Systemic Infection Therapy Product Table 137. Baiyunshan Pharmaceutical Recent Developments/Updates Table 138. Harbin Pharmaceutical Corporation Information Table 139. Harbin Pharmaceutical Description and Business Overview Table 140. Harbin Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. Harbin Pharmaceutical Systemic Infection Therapy Product Table 142. Harbin Pharmaceutical Recent Developments/Updates Table 143. China National Pharmaceutical Corporation Information Table 144. China National Pharmaceutical Description and Business Overview Table 145. China National Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. China National Pharmaceutical Systemic Infection Therapy Product Table 147. China National Pharmaceutical Recent Developments/Updates Table 148. Luoxin Pharmaceuticals Corporation Information Table 149. Luoxin Pharmaceuticals Description and Business Overview Table 150. Luoxin Pharmaceuticals Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Luoxin Pharmaceuticals Systemic Infection Therapy Product Table 152. Luoxin Pharmaceuticals Recent Developments/Updates Table 153. Yangtze River Pharmaceutical Corporation Information Table 154. Yangtze River Pharmaceutical Description and Business Overview Table 155. Yangtze River Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. Yangtze River Pharmaceutical Systemic Infection Therapy Product Table 157. Yangtze River Pharmaceutical Recent Developments/Updates Table 158. China Resources Pharmaceutical Corporation Information Table 159. China Resources Pharmaceutical Description and Business Overview Table 160. China Resources Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 161. China Resources Pharmaceutical Systemic Infection Therapy Product Table 162. China Resources Pharmaceutical Recent Developments/Updates Table 163. North China Pharmaceutical Corporation Information Table 164. North China Pharmaceutical Description and Business Overview Table 165. North China Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 166. North China Pharmaceutical Systemic Infection Therapy Product Table 167. North China Pharmaceutical Recent Developments/Updates Table 168. ReYoung Pharmaceutical Corporation Information Table 169. ReYoung Pharmaceutical Description and Business Overview Table 170. ReYoung Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 171. ReYoung Pharmaceutical Systemic Infection Therapy Product Table 172. ReYoung Pharmaceutical Recent Developments/Updates Table 173. Chia Tai-Tianqing Pharmaceutical Corporation Information Table 174. Chia Tai-Tianqing Pharmaceutical Description and Business Overview Table 175. Chia Tai-Tianqing Pharmaceutical Systemic Infection Therapy Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 176. Chia Tai-Tianqing Pharmaceutical Systemic Infection Therapy Product Table 177. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates Table 178. Production Base and Market Concentration Rate of Raw Material Table 179. Key Suppliers of Raw Materials Table 180. Systemic Infection Therapy Distributors List Table 181. Systemic Infection Therapy Customers List Table 182. Systemic Infection Therapy Market Trends Table 183. Systemic Infection Therapy Growth Drivers Table 184. Systemic Infection Therapy Market Challenges Table 185. Systemic Infection Therapy Market Restraints Table 186. Global Systemic Infection Therapy Sales Forecast by Type (2022-2027) & (K Units) Table 187. Global Systemic Infection Therapy Sales Market Share Forecast by Type (2022-2027) Table 188. Global Systemic Infection Therapy Revenue Forecast by Type (2022-2027) & (US$ Million) Table 189. Global Systemic Infection Therapy Revenue Market Share Forecast by Type (2022-2027) Table 190. Global Systemic Infection Therapy Sales Forecast by Application (2022-2027) & (K Units) Table 191. Global Systemic Infection Therapy Sales Market Share Forecast by Application (2022-2027) Table 192. Global Systemic Infection Therapy Revenue Forecast by Application (2022-2027) & (US$ Million) Table 193. Global Systemic Infection Therapy Revenue Market Share Forecast by Application (2022-2027) Table 194. Global Systemic Infection Therapy Sales Forecast by Region (2022-2027) & (K Units) Table 195. Global Systemic Infection Therapy Sales Market Share Forecast by Region (2022-2027) Table 196. Global Systemic Infection Therapy Revenue Forecast by Region (2022-2027) & (US$ Million) Table 197. Global Systemic Infection Therapy Revenue Market Share Forecast by Region (2022-2027) Table 198. Research Programs/Design for This Report Table 199. Key Data Information from Secondary Sources Table 200. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Systemic Infection Therapy Figure 2. Global Systemic Infection Therapy Market Share by Type in 2020 & 2027 Figure 3. Antibacterial Drugs Product Picture Figure 4. Anti-viral Drugs Product Picture Figure 5. Antifungal Drugs Product Picture Figure 6. Global Systemic Infection Therapy Market Share by Application in 2020 & 2027 Figure 7. Oral Figure 8. Intravenous Figure 9. Topical Figure 10. Global Systemic Infection Therapy Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Systemic Infection Therapy Market Size 2016-2027 (US$ Million) Figure 12. Global Systemic Infection Therapy Sales 2016-2027 (K Units) Figure 13. Global Systemic Infection Therapy Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Systemic Infection Therapy Sales Share by Manufacturers in 2020 Figure 15. Global Systemic Infection Therapy Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Systemic Infection Therapy Players: Market Share by Revenue in 2020 Figure 17. Systemic Infection Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Systemic Infection Therapy Sales Market Share by Region (2016-2021) Figure 19. Global Systemic Infection Therapy Sales Market Share by Region in 2020 Figure 20. Global Systemic Infection Therapy Revenue Market Share by Region (2016-2021) Figure 21. Global Systemic Infection Therapy Revenue Market Share by Region in 2020 Figure 22. United States Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Taiwan Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. UAE Systemic Infection Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Systemic Infection Therapy by Type (2016-2021) Figure 45. Sales Market Share of Systemic Infection Therapy by Application (2016-2021) Figure 46. Sales Market Share of Systemic Infection Therapy by Application in 2020 Figure 47. Revenue Share of Systemic Infection Therapy by Application (2016-2021) Figure 48. Revenue Share of Systemic Infection Therapy by Application in 2020 Figure 49. Manufacturing Cost Structure of Systemic Infection Therapy Figure 50. Manufacturing Process Analysis of Systemic Infection Therapy Figure 51. Systemic Infection Therapy Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Abbott Laboratories Merck & Co. Pfizer GlaxoSmithKline Novartis Johnson & Johnson Sun Pharmaceuticals Roche Astra Zeneca Wockhardt Mylan Pharma MicuRx Pharmaceuticals Jincheng Pharmaceutical Renhe Pharmacy Hengrui Medicine Huluwa Pharmaceutical Fushine Pharmaceutical Baiyunshan Pharmaceutical Harbin Pharmaceutical China National Pharmaceutical Luoxin Pharmaceuticals Yangtze River Pharmaceutical China Resources Pharmaceutical North China Pharmaceutical ReYoung Pharmaceutical Chia Tai-Tianqing Pharmaceutical